Iconovo (Sweden) Insiders

ICO Stock  SEK 1.14  0.04  3.64%   
Iconovo employs about 31 people. The company is managed by 6 executives with a total tenure of roughly 73 years, averaging almost 12.0 years of service per executive, having 5.17 employees per reported executive. Breaking down Iconovo's management performance can provide insight into the firm performance.
Carl Forslund  Insider
Head Design
Orest Lastow  Insider
CoFounder CTO
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iconovo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Iconovo Management Team Effectiveness

The company has return on total asset (ROA) of (0.1732) % which means that it has lost $0.1732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3195) %, meaning that it generated substantial loss on money invested by shareholders. Iconovo's management efficiency ratios could be used to measure how well Iconovo manages its routine affairs as well as how well it operates its assets and liabilities.
The market capitalization of Iconovo is kr389.29 Million. Iconovo secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Iconovo Workforce Comparison

Iconovo is currently regarded as number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 206. Iconovo retains roughly 31.0 in number of employees claiming about 15% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of (1.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.2.

Iconovo Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Iconovo Price Series Summation is a cross summation of Iconovo price series and its benchmark/peer.

Iconovo Notable Stakeholders

An Iconovo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Iconovo often face trade-offs trying to please all of them. Iconovo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Iconovo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Carl ForslundHead DesignProfile
Orest LastowCoFounder CTOProfile
Mikael ArinderVP OperationsProfile
Johan WaborgChief OfficerProfile
Peter AkerlundChief OfficerProfile
Eva NorellCommunications MangProfile
String symbol = request.getParameter("s");

About Iconovo Management Performance

The success or failure of an entity such as Iconovo often depends on how effective the management is. Iconovo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Iconovo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Iconovo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Iconovo AB develops and licenses inhalation devices in Sweden. Iconovo AB was founded in 2013 and is based in Lund, Sweden. Iconovo AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 27 people.
Please note, the imprecision that can be found in Iconovo's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Iconovo. Check Iconovo's Beneish M Score to see the likelihood of Iconovo's management manipulating its earnings.

Iconovo Workforce Analysis

Traditionally, organizations such as Iconovo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Iconovo within its industry.

Iconovo Manpower Efficiency

Return on Iconovo Manpower

Revenue Per Employee497.1K
Revenue Per Executive2.6M
Net Loss Per Employee843.9K
Net Loss Per Executive4.4M

Additional Tools for Iconovo Stock Analysis

When running Iconovo's price analysis, check to measure Iconovo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iconovo is operating at the current time. Most of Iconovo's value examination focuses on studying past and present price action to predict the probability of Iconovo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iconovo's price. Additionally, you may evaluate how the addition of Iconovo to your portfolios can decrease your overall portfolio volatility.